Research & Development
African research consortium awarded $5.3M by EU Horizon Europe program to combat epidemics
A research consortium led by Stellenbosch University in Stellenbosch, South Africa, was awarded 5 million euros ($5.3 million) from the EU Horizon Europe program for genomic research in combating epidemics in Africa.
September 18, 2023
U.K. charity to offer $1.6M in grants for research on muscle-wasting diseases
U.K. research projects will benefit from 1.3 million pounds ($1.6 million) in grants to improve diagnostic testing and potential new treatments for muscle-wasting and -weakening conditions.
September 14, 2023
Actome outlines sequencing expansion plans as EU funding kicks in
Actome has outlined how funding from the European Innovation Council (EIC) will support work to adapt its technology to enable the measurement of “50 to 100 antibodies at the same time in a single cell.”
September 7, 2023
Consortium nabs $10M European grant to develop drug response tests for CKD
The Prime-CKD consortium is funded by Horizon Europe. Approximately $1 million of the total amount is targeted for commercial translation activities to be undertaken by Renalytix.
January 26, 2023
Diadem nabs $2.5M to further validate Alzheimer’s blood test
The two-year grant will enable Diadem, a company that has been developing a blood-based test for the early prediction of Alzheimer's disease (AD), to leverage data from the Alzheimer's Disease Neuroimaging Initiative (ADNI), a longitudinal multicenter study designed to enable development of biomarkers for the early detection and tracking of AD.
September 6, 2022
VolitionRx prices $6M public offering
The company said that gross proceeds to Volition from the offering are expected to be $6 million. Volition also granted the underwriter a 30-day option to purchase up to an additional 450,000 shares of its common stock at the public offering price. The offering is expected to close on or about August 2.
July 28, 2022
AACR announces 2022 cancer research award recipients
The award recognizes female researchers who have made pioneering contributions to the understanding and treatment of breast and gynecological cancer. This year's awardees include:
April 3, 2022
Foundation Medicine secures FDA 'breakthrough' designation
The FDA granted the designation for use of the assay in detecting molecular residual disease (MRD) in early-stage cancer after curative therapy. These test results can then help to guide further treatment decisions in these patients, according to the vendor.
February 14, 2022
SLAS 2022: 6 tips for scientists looking to start companies
1. Find the right team
February 8, 2022
Fla. university awarded $1.3M from NIH for HIV test
With the grant, FAU researchers hope to develop an affordable, disposable self-testing HIV-1 chip that can selectively detect HIV from whole blood samples. The researchers are aiming for an automated test that requires no refrigeration and can produce results within 40 minutes. They also said it will be sensitive enough to detect HIV during acute infection, treatment, and viral rebound, according to a press release issued by the university.
January 17, 2022
Siemens gets FDA nod for ELF test for liver fibrosis
ELF is a noninvasive blood test intended for use with the company's Advia Centaur XP immunoassay system. The test provides a numeric score that is automatically generated via an algorithm and is used to assess the likelihood of progressing to cirrhosis and liver-related clinical events in patients with severe or advanced fibrosis (F3 or F4) due to nonalcoholic steatohepatitis (NASH).
August 23, 2021
Researchers get $3.3M to study AI in oral cancer
The U.S. National Cancer Institute awarded the five-year grant to a group led by Anant Madabhushi, PhD, the Donnell Institute Professor of Biomedical Engineering at CWRU and head of the Center for Computational Imaging and Personalized Diagnostics, and Dr. James Lewis Jr., a pathology, microbiology, and immunology professor at Vanderbilt University Medical Center.
January 5, 2021
Page 1 of 3